ArrowMark Colorado Holdings’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.3M Sell
1,374,103
-187,346
-12% -$6.93M 1.18% 17
2025
Q4
$65.7M Sell
1,561,449
-984,290
-39% -$39.7M 1.45% 7
2025
Q3
$87.4M Sell
2,545,739
-33,084
-1% -$949K 1.62% 7
2025
Q2
$69.7M Sell
2,578,823
-647,850
-20% -$18.8M 1.26% 24
2025
Q1
$95.7M Buy
3,226,673
+146,646
+5% +$5.59M 1.55% 13
2024
Q4
$122M Buy
3,080,027
+97,824
+3% +$3.7M 1.64% 12
2024
Q3
$102M Sell
2,982,203
-15,580
-0.5% -$438K 1.3% 21
2024
Q2
$65M Buy
2,997,783
+354,538
+13% +$7.45M 0.77% 37
2024
Q1
$58.6M Buy
2,643,245
+126,105
+5% +$3.08M 0.66% 46
2023
Q4
$69.2M Buy
2,517,140
+206,281
+9% +$4.98M 0.76% 42
2023
Q3
$51.6M Sell
2,310,859
-80,120
-3% -$2.06M 0.63% 54
2023
Q2
$60.9M Buy
2,390,979
+178,414
+8% +$4.32M 0.67% 50
2023
Q1
$49.3M Sell
2,212,565
-577,105
-21% -$13.9M 0.56% 55
2022
Q4
$66.2M Sell
2,789,670
-59,750
-2% -$1.39M 0.79% 44
2022
Q3
$47.3M Sell
2,849,420
-852,556
-23% -$19.2M 0.58% 54
2022
Q2
$73.7M Buy
3,701,976
+612,533
+20% +$12.4M 0.84% 40
2022
Q1
$85.2M Buy
3,089,443
+562,021
+22% +$16.1M 0.75% 41
2021
Q4
$104M Buy
2,527,422
+18,172
+0.7% +$803K 0.83% 36
2021
Q3
$117M Sell
2,509,250
-23,338
-0.9% -$1.02M 0.91% 31
2021
Q2
$101M Buy
2,532,588
+1,008,289
+66% +$43.1M 0.76% 42
2021
Q1
$81.9M Buy
1,524,299
+735,121
+93% +$42.3M 0.61% 50
2020
Q4
$38.6M Sell
789,178
-63,022
-7% -$2.92M 0.3% 87
2020
Q3
$27.7M Sell
852,200
-272,583
-24% -$8.66M 0.26% 88
2020
Q2
$29.1M Sell
1,124,783
-22
-0% -$548 0.3% 82
2020
Q1
$27.3M Buy
+1,124,805
New +$28.3M 0.36% 75

Other funds holding VCYT

ArrowMark Colorado Holdings's VCYT Position: Q1 2026 in Review

ArrowMark Colorado Holdings reduced its Veracyte (VCYT) stake by 12% in Q1 2026, selling an estimated $6.93M and leaving 1,374,103 shares worth $44.3M. The position accounts for 1.18% of the portfolio, ranked #17.

ArrowMark Colorado Holdings first reported a position in VCYT in Q1 2020 and has held it in 25 quarters since. The position peaked at $122M in Q4 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • ArrowMark Colorado Holdings held 1,374,103 shares of Veracyte worth $44.3M as of Q1 2026.
  • ArrowMark Colorado Holdings sold 187,346 Veracyte shares in Q1 2026, an estimated $6.93M.
  • Veracyte made up 1.18% of ArrowMark Colorado Holdings's portfolio in Q1 2026, its #17 holding.
  • ArrowMark Colorado Holdings first reported a position in Veracyte in Q1 2020 and has held it in 25 quarters since.
  • ArrowMark Colorado Holdings's Veracyte position peaked at $122M in Q4 2024.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2026, filed 15 May 2026.